Lifileucel 获批标志着晚期黑色素瘤治疗取得进展

{"title":"Lifileucel 获批标志着晚期黑色素瘤治疗取得进展","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001017088.72742.82","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19516,"journal":{"name":"Oncology Times","volume":"29 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lifileucel Approval Signals Progress in Advanced Melanoma Treatment\",\"authors\":\"Dibash Kumar Das\",\"doi\":\"10.1097/01.cot.0001017088.72742.82\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19516,\"journal\":{\"name\":\"Oncology Times\",\"volume\":\"29 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology Times\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.cot.0001017088.72742.82\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Times","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.cot.0001017088.72742.82","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}